| Year |
Citation |
Score |
| 2021 |
Tropea TF, Amari N, Han N, Rick J, Suh E, Akhtar RS, Dahodwala N, Deik A, Gonzalez-Alegre P, Hurtig H, Siderowf A, Spindler M, Stern M, Thenganatt MA, Weintraub D, et al. Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study. Journal of Parkinson's Disease. PMID 33492247 DOI: 10.3233/JPD-202406 |
0.429 |
|
| 2020 |
Siderowf A, Jennings D, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 32657461 DOI: 10.1002/Mds.28139 |
0.347 |
|
| 2018 |
Berg D, Adler CH, Bloem BR, Chan P, Gasser T, Goetz CG, Halliday G, Lang AE, Lewis S, Li Y, Liepelt-Scarfone I, Litvan I, Marek K, Maetzler C, Mi T, ... Stern M, et al. Movement disorder society criteria for clinically established early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 30145841 DOI: 10.1002/Mds.27431 |
0.427 |
|
| 2017 |
Chahine LM, Stern MB. Parkinson's Disease Biomarkers: Where Are We and Where Do We Go Next? Movement Disorders Clinical Practice. 4: 796-805. PMID 30363472 DOI: 10.1002/mdc3.12545 |
0.434 |
|
| 2017 |
Weintraub D, Chahine LM, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D. Cognition and the course of prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 29063713 DOI: 10.1002/Mds.27189 |
0.357 |
|
| 2017 |
Fullard ME, Xie SX, Marek K, Stern M, Jennings D, Siderowf A, Willis AW, Chen-Plotkin AS. Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 28906025 DOI: 10.1002/Mds.27127 |
0.32 |
|
| 2017 |
Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort. Jama Neurology. PMID 28595287 DOI: 10.1001/Jamaneurol.2017.0985 |
0.441 |
|
| 2016 |
Postuma RB, Berg D, Adler CH, Bloem BR, Chan P, Deuschl G, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Oertel W, ... Stern M, et al. The new definition and diagnostic criteria of Parkinson's disease. The Lancet. Neurology. 15: 546-8. PMID 27302120 DOI: 10.1016/S1474-4422(16)00116-2 |
0.372 |
|
| 2016 |
Lim NS, Swanson CR, Cherng HR, Unger TL, Xie SX, Weintraub D, Marek K, Stern MB, Siderowf A, Trojanowski JQ, Chen-Plotkin AS. Plasma EGF and cognitive decline in Parkinson's disease and Alzheimer's disease. Annals of Clinical and Translational Neurology. 3: 346-55. PMID 27231704 DOI: 10.1002/Acn3.299 |
0.41 |
|
| 2016 |
Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. The Penn Parkinson's Daily Activities Questionnaire-15: Psychometric properties of a brief assessment of cognitive instrumental activities of daily living in Parkinson's disease. Parkinsonism & Related Disorders. PMID 26923524 DOI: 10.1016/J.Parkreldis.2016.02.020 |
0.402 |
|
| 2015 |
Berg D, Postuma RB, Adler CH, Bloem BR, Chan P, Dubois B, Gasser T, Goetz CG, Halliday G, Joseph L, Lang AE, Liepelt-Scarfone I, Litvan I, Marek K, Obeso J, ... ... Stern M, et al. MDS research criteria for prodromal Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1600-11. PMID 26474317 DOI: 10.1002/Mds.26431 |
0.438 |
|
| 2015 |
Postuma RB, Berg D, Stern M, Poewe W, Olanow CW, Oertel W, Obeso J, Marek K, Litvan I, Lang AE, Halliday G, Goetz CG, Gasser T, Dubois B, Chan P, et al. MDS clinical diagnostic criteria for Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 30: 1591-601. PMID 26474316 DOI: 10.1002/Mds.26424 |
0.425 |
|
| 2015 |
Chahine LM, Weintraub D, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26293177 DOI: 10.1002/mds.26373 |
0.382 |
|
| 2015 |
Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 26249849 DOI: 10.1002/Mds.26339 |
0.372 |
|
| 2015 |
Katz M, Luciano MS, Carlson K, Luo P, Marks WJ, Larson PS, Starr PA, Follett KA, Weaver FM, Stern MB, Reda DJ, Ostrem JL. Differential effects of deep brain stimulation target on motor subtypes in Parkinson's disease. Annals of Neurology. 77: 710-9. PMID 25627340 DOI: 10.1002/ana.24374 |
0.393 |
|
| 2015 |
Rothlind JC, York MK, Carlson K, Luo P, Marks WJ, Weaver FM, Stern M, Follett K, Reda D. Neuropsychological changes following deep brain stimulation surgery for Parkinson's disease: comparisons of treatment at pallidal and subthalamic targets versus best medical therapy. Journal of Neurology, Neurosurgery, and Psychiatry. 86: 622-9. PMID 25185211 DOI: 10.1136/Jnnp-2014-308119 |
0.399 |
|
| 2015 |
Chahine LM, Weintraub D, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D. Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings Movement Disorders. DOI: 10.1002/mds.26373 |
0.323 |
|
| 2015 |
Brennan L, Siderowf A, Rubright JD, Rick J, Dahodwala N, Duda JE, Hurtig H, Stern M, Xie SX, Rennert L, Karlawish J, Shea JA, Trojanowski JQ, Weintraub D. Development and initial testing of the Penn Parkinson's Daily Activities Questionnaire Movement Disorders. DOI: 10.1002/mds.26339 |
0.327 |
|
| 2014 |
Chahine LM, Stern MB. Characterizing Premotor Parkinson's Disease: Clinical Features and Objective Markers. Movement Disorders Clinical Practice. 1: 299-306. PMID 30363867 DOI: 10.1002/mdc3.12062 |
0.408 |
|
| 2014 |
Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K. Imaging prodromal Parkinson disease: the Parkinson Associated Risk Syndrome Study. Neurology. 83: 1739-46. PMID 25298306 DOI: 10.1212/Wnl.0000000000000960 |
0.389 |
|
| 2014 |
Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, Minger J, Weintraub D. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 83: 826-33. PMID 25037206 DOI: 10.1212/Wnl.0000000000000729 |
0.408 |
|
| 2014 |
Berg D, Postuma RB, Bloem B, Chan P, Dubois B, Gasser T, Goetz CG, Halliday GM, Hardy J, Lang AE, Litvan I, Marek K, Obeso J, Oertel W, Olanow CW, ... ... Stern M, et al. Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29: 454-62. PMID 24619848 DOI: 10.1002/Mds.25844 |
0.438 |
|
| 2014 |
Chahine LM, Stern MB, Chen-Plotkin A. Blood-based biomarkers for Parkinson's disease. Parkinsonism & Related Disorders. 20: S99-103. PMID 24262199 DOI: 10.1016/S1353-8020(13)70025-7 |
0.368 |
|
| 2013 |
Grossman M, Carvell S, Gollomp S, Stern MB, Reivich M, Morrison D, Alavi A, Hurtig HI. Cognitive and physiological substrates of impaired sentence processing in Parkinson's disease. Journal of Cognitive Neuroscience. 5: 480-98. PMID 23964920 DOI: 10.1162/jocn.1993.5.4.480 |
0.359 |
|
| 2013 |
Fleisher JE, Stern MB. Medication nonadherence in Parkinson's disease. Current Neurology and Neuroscience Reports. 13: 382. PMID 23954970 DOI: 10.1007/s11910-013-0382-z |
0.349 |
|
| 2013 |
Weintraub D, Duda JE, Carlson K, Luo P, Sagher O, Stern M, Follett KA, Reda D, Weaver FM. Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial. Journal of Neurology, Neurosurgery, and Psychiatry. 84: 1113-8. PMID 23667214 DOI: 10.1136/jnnp-2012-304396 |
0.379 |
|
| 2013 |
Berg D, Lang AE, Postuma RB, Maetzler W, Deuschl G, Gasser T, Siderowf A, Schapira AH, Oertel W, Obeso JA, Olanow CW, Poewe W, Stern M. Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. The Lancet. Neurology. 12: 514-24. PMID 23582175 DOI: 10.1016/S1474-4422(13)70047-4 |
0.396 |
|
| 2013 |
Gross RG, Camp E, McMillan CT, Dreyfuss M, Gunawardena D, Cook PA, Morgan B, Siderowf A, Hurtig HI, Stern MB, Grossman M. Impairment of script comprehension in Lewy body spectrum disorders. Brain and Language. 125: 330-43. PMID 23566691 DOI: 10.1016/J.Bandl.2013.02.006 |
0.366 |
|
| 2013 |
Qiang JK, Wong YC, Siderowf A, Hurtig HI, Xie SX, Lee VM, Trojanowski JQ, Yearout D, B Leverenz J, Montine TJ, Stern M, Mendick S, Jennings D, Zabetian C, Marek K, et al. Plasma apolipoprotein A1 as a biomarker for Parkinson disease. Annals of Neurology. 74: 119-27. PMID 23447138 DOI: 10.1002/Ana.23872 |
0.409 |
|
| 2012 |
Akhtar RS, Stern MB. New concepts in the early and preclinical detection of Parkinson's disease: therapeutic implications. Expert Review of Neurotherapeutics. 12: 1429-38. PMID 23237350 DOI: 10.1586/ern.12.144 |
0.39 |
|
| 2012 |
Dahodwala N, Karlawish J, Shea JA, Zubritsky C, Stern M, Mandell DS. Validation of an instrument to measure older adults' expectations regarding movement (ERM). Plos One. 7: e43854. PMID 22937110 DOI: 10.1371/journal.pone.0043854 |
0.346 |
|
| 2012 |
Weaver FM, Follett KA, Stern M, Luo P, Harris CL, Hur K, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology. 79: 55-65. PMID 22722632 DOI: 10.1212/Wnl.0B013E31825Dcdc1 |
0.372 |
|
| 2012 |
Morley JF, Xie SX, Hurtig HI, Stern MB, Colcher A, Horn S, Dahodwala N, Duda JE, Weintraub D, Chen-Plotkin AS, Van Deerlin V, Falcone D, Siderowf A. Genetic influences on cognitive decline in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 512-8. PMID 22344634 DOI: 10.1002/Mds.24946 |
0.397 |
|
| 2012 |
Stern MB, Lang A, Poewe W. Toward a redefinition of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 54-60. PMID 22252891 DOI: 10.1002/mds.24051 |
0.391 |
|
| 2012 |
Siderowf A, Jennings D, Eberly S, Oakes D, Hawkins KA, Ascherio A, Stern MB, Marek K. Impaired olfaction and other prodromal features in the Parkinson At-Risk Syndrome Study. Movement Disorders : Official Journal of the Movement Disorder Society. 27: 406-12. PMID 22237833 DOI: 10.1002/Mds.24892 |
0.385 |
|
| 2012 |
Tolosa E, Stern MB. Efficacy, safety and tolerability of rasagiline as adjunctive therapy in elderly patients with Parkinson's disease. European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies. 19: 258-64. PMID 21819487 DOI: 10.1111/j.1468-1331.2011.03484.x |
0.425 |
|
| 2012 |
Weintraub D, Stern MB. Disorders of mood and affect in Parkinson's disease. Handbook of Clinical Neurology. 83: 421-33. PMID 18808926 DOI: 10.1016/S0072-9752(07)83019-3 |
0.35 |
|
| 2012 |
Stern M, Weiss AA, Toscani M. Does patient self-reported data have a role in the longitudinal study of Parkinson's disease? An analysis of the PROPATHtrade mark database. Parkinsonism & Related Disorders. 3: 89-96. PMID 18591061 DOI: 10.1016/S1353-8020(97)00005-9 |
0.407 |
|
| 2011 |
Chahine LM, Stern MB. Rasagiline in Parkinson's disease. International Review of Neurobiology. 100: 151-68. PMID 21971007 DOI: 10.1016/B978-0-12-386467-3.00008-X |
0.437 |
|
| 2011 |
Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T, Coffey C, Kieburtz K, Flagg E, Chowdhury S, Poewe W, Mollenhauer B, Sherer T, Frasier M, Meunier C, ... ... Stern M, et al. The Parkinson Progression Marker Initiative (PPMI) Progress in Neurobiology. 95: 629-635. PMID 21930184 DOI: 10.1016/J.Pneurobio.2011.09.005 |
0.312 |
|
| 2011 |
Rascol O, Lozano A, Stern M, Poewe W. Milestones in Parkinson's disease therapeutics. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1072-82. PMID 21626552 DOI: 10.1002/Mds.23714 |
0.391 |
|
| 2011 |
Halliday G, Lees A, Stern M. Milestones in Parkinson's disease--clinical and pathologic features. Movement Disorders : Official Journal of the Movement Disorder Society. 26: 1015-21. PMID 21626546 DOI: 10.1002/mds.23669 |
0.359 |
|
| 2011 |
Chahine LM, Stern MB. Diagnostic markers for Parkinson's disease. Current Opinion in Neurology. 24: 309-17. PMID 21464716 DOI: 10.1097/WCO.0b013e3283461723 |
0.389 |
|
| 2010 |
Marks WJ, Bartus RT, Siffert J, Davis CS, Lozano A, Boulis N, Vitek J, Stacy M, Turner D, Verhagen L, Bakay R, Watts R, Guthrie B, Jankovic J, Simpson R, ... Stern M, et al. Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trial. The Lancet. Neurology. 9: 1164-72. PMID 20970382 DOI: 10.1016/S1474-4422(10)70254-4 |
0.362 |
|
| 2010 |
Kleiner-Fisman G, Stern MB, Fisman DN. Health-Related Quality of Life in Parkinson disease: Correlation between Health Utilities Index III and Unified Parkinson's Disease Rating Scale (UPDRS) in U.S. male veterans Health and Quality of Life Outcomes. 8. PMID 20799993 DOI: 10.1186/1477-7525-8-91 |
0.36 |
|
| 2010 |
Weintraub D, Mavandadi S, Mamikonyan E, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Nazem S, Ten Have TR, Stern MB. Atomoxetine for depression and other neuropsychiatric symptoms in Parkinson disease. Neurology. 75: 448-55. PMID 20679638 DOI: 10.1212/Wnl.0B013E3181Ebdd79 |
0.367 |
|
| 2010 |
Stephenson R, Houghton D, Sundarararjan S, Doty RL, Stern M, Xie SX, Siderowf A. Odor identification deficits are associated with increased risk of neuropsychiatric complications in patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 2099-104. PMID 20669288 DOI: 10.1002/Mds.23234 |
0.408 |
|
| 2010 |
Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, Weintraub D. Decreased ventral striatal activity with impulse control disorders in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 1660-9. PMID 20589879 DOI: 10.1002/mds.23147 |
0.43 |
|
| 2010 |
Follett KA, Weaver FM, Stern M, Hur K, Harris CL, Luo P, Marks WJ, Rothlind J, Sagher O, Moy C, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. The New England Journal of Medicine. 362: 2077-91. PMID 20519680 DOI: 10.1056/Nejmoa0907083 |
0.332 |
|
| 2010 |
Watts RL, Lyons KE, Pahwa R, Sethi K, Stern M, Hauser RA, Olanow W, Gray AM, Adams B, Earl NL. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25: 858-66. PMID 20461803 DOI: 10.1002/mds.22890 |
0.405 |
|
| 2010 |
Stern MB, Siderowf A. Parkinson's at risk syndrome: Can Parkinson's disease be predicted? Movement Disorders. 25: S89-S93. PMID 20187248 DOI: 10.1002/mds.22719 |
0.455 |
|
| 2009 |
Hoops S, Nazem S, Siderowf AD, Duda JE, Xie SX, Stern MB, Weintraub D. Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology. 73: 1738-45. PMID 19933974 DOI: 10.1212/Wnl.0B013E3181C34B47 |
0.406 |
|
| 2009 |
Stephenson R, Siderowf A, Stern MB. Premotor Parkinson's disease: clinical features and detection strategies. Movement Disorders : Official Journal of the Movement Disorder Society. 24: S665-70. PMID 19877244 DOI: 10.1002/mds.22403 |
0.41 |
|
| 2009 |
Mavandadi S, Nazem S, Ten Have TR, Siderowf AD, Duda JE, Stern MB, Weintraub D. Use of latent variable modeling to delineate psychiatric and cognitive profiles in Parkinson disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 17: 986-95. PMID 19855199 DOI: 10.1097/Jgp.0B013E3181B215Ec |
0.375 |
|
| 2009 |
Olanow CW, Stern MB, Sethi K. The scientific and clinical basis for the treatment of Parkinson disease (2009) Neurology. 72: S1-S136. PMID 19470958 DOI: 10.1212/WNL.0b013e3181a1d44c |
0.439 |
|
| 2009 |
Weintraub D, Hoops S, Shea JA, Lyons KE, Pahwa R, Driver-Dunckley ED, Adler CH, Potenza MN, Miyasaki J, Siderowf AD, Duda JE, Hurtig HI, Colcher A, Horn SS, Stern MB, et al. Validation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1461-7. PMID 19452562 DOI: 10.1002/mds.22571 |
0.362 |
|
| 2009 |
Dahodwala N, Siderowf A, Xie M, Noll E, Stern M, Mandell DS. Racial differences in the diagnosis of Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24: 1200-5. PMID 19412929 DOI: 10.1002/mds.22557 |
0.413 |
|
| 2009 |
Phuong L, Garg S, Duda JE, Stern MB, Weintraub D. Involuntary emotional expression disorder (IEED) in Parkinson's disease Parkinsonism and Related Disorders. 15: 511-515. PMID 19181560 DOI: 10.1016/j.parkreldis.2009.01.001 |
0.393 |
|
| 2009 |
Nazem S, Siderowf AD, Duda JE, Have TT, Colcher A, Horn SS, Moberg PJ, Wilkinson JR, Hurtig HI, Stern MB, Weintraub D. Montreal cognitive assessment performance in patients with Parkinson's disease with "normal" global cognition according to mini-mental state examination score. Journal of the American Geriatrics Society. 57: 304-8. PMID 19170786 DOI: 10.1111/J.1532-5415.2008.02096.X |
0.361 |
|
| 2009 |
Weaver FM, Follett K, Stern M, Hur K, Harris C, Marks WJ, Rothlind J, Sagher O, Reda D, Moy CS, Pahwa R, Burchiel K, Hogarth P, Lai EC, Duda JE, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. Jama. 301: 63-73. PMID 19126811 DOI: 10.1001/Jama.2008.929 |
0.394 |
|
| 2009 |
Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D. Mild cognitive impairment is common in Parkinson's disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism & Related Disorders. 15: 226-31. PMID 18595765 DOI: 10.1016/J.Parkreldis.2008.05.006 |
0.359 |
|
| 2009 |
Marks W, Bartus R, Siffert J, Starr P, Ostrem J, Stacy M, Boulis N, Vitek J, Verhagen L, Watts R, Jankovic J, Tagliati M, Stern M, Nutt J, Kordower J, et al. P2.113 Multicenter, randomized, double-blind, sham surgery-controlled study of intraputaminal AAV2-neurturin (CERE-120) for advanced Parkinson's disease (PD) Parkinsonism & Related Disorders. 15: S120. DOI: 10.1016/S1353-8020(09)70464-X |
0.312 |
|
| 2008 |
Siderowf A, Stern MB. Premotor Parkinson's disease: Clinical features, detection, and prospects for treatment Annals of Neurology. 64: S139-S147. PMID 19127581 DOI: 10.1002/ana.21462 |
0.42 |
|
| 2008 |
Olanow CW, Stern MB. Parkinson's disease: Unresolved issues Annals of Neurology. 64: S1-S2. PMID 19127574 DOI: 10.1002/ana.21501 |
0.389 |
|
| 2008 |
Goetz CG, Tilley BC, Shaftman SR, Stebbins GT, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stern MB, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 2129-70. PMID 19025984 DOI: 10.1002/Mds.22340 |
0.352 |
|
| 2008 |
Nazem S, Siderowf AD, Duda JE, Brown GK, Ten Have T, Stern MB, Weintraub D. Suicidal and death ideation in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 23: 1573-9. PMID 18618660 DOI: 10.1002/Mds.22130 |
0.371 |
|
| 2008 |
Oehlberg K, Barg FK, Brown GK, Taraborelli D, Stern MB, Weintraub D. Attitudes regarding the etiology and treatment of depression in Parkinson's disease: a qualitative study. Journal of Geriatric Psychiatry and Neurology. 21: 123-32. PMID 18474721 DOI: 10.1177/0891988708316862 |
0.348 |
|
| 2008 |
Stern MB. Transcranial ultrasound in Parkinson's disease The Lancet Neurology. 7: 376-378. PMID 18394966 DOI: 10.1016/S1474-4422(08)70068-1 |
0.385 |
|
| 2008 |
Mamikonyan E, Siderowf AD, Duda JE, Potenza MN, Horn S, Stern MB, Weintraub D. Long-term follow-up of impulse control disorders in Parkinson's disease Movement Disorders. 23: 75-80. PMID 17960796 DOI: 10.1002/mds.21770 |
0.412 |
|
| 2007 |
May S, Gilman S, Sowell BB, Thomas RG, Stern MB, Colcher A, Tanner CM, Huang N, Novak P, Reich SG, Jankovic J, Ondo WG, Low PA, Sandroni P, Lipp A, et al. Potential outcome measures and trial design issues for multiple system atrophy. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2371-7. PMID 17914727 DOI: 10.1002/Mds.21734 |
0.301 |
|
| 2007 |
Siderowf A, Jennings D, Connolly J, Doty RL, Marek K, Stern MB. Risk factors for Parkinson's disease and impaired olfaction in relatives of patients with Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 2249-55. PMID 17876851 DOI: 10.1002/mds.21707 |
0.428 |
|
| 2007 |
Moberg PJ, Balderston CC, Rick JH, Roalf DR, Weintraub D, Kleiner-Fisman G, Stern MB, Duda JE. Phenylthiocarbamide (PTC) perception in Parkinson disease. Cognitive and Behavioral Neurology : Official Journal of the Society For Behavioral and Cognitive Neurology. 20: 145-8. PMID 17846512 DOI: 10.1097/WNN.0b013e31812570c3 |
0.439 |
|
| 2007 |
Dennison AC, Noorigian JV, Robinson KM, Fisman DN, Cianci HJ, Moberg P, Bunting-Perry L, Martine R, Duda J, Stern MB. Falling in Parkinson disease: identifying and prioritizing risk factors in recurrent fallers. American Journal of Physical Medicine & Rehabilitation / Association of Academic Physiatrists. 86: 621-32. PMID 17667192 DOI: 10.1097/PHM.0b013e311611583 |
0.308 |
|
| 2007 |
Weintraub D, Stern MB. Intervening in the neuropsychiatric features of Parkinson's disease Expert Review of Neurotherapeutics. 7: 699-710. PMID 17563252 DOI: 10.1586/14737175.7.6.699 |
0.377 |
|
| 2007 |
Weintraub D, Saboe K, Stern MB. Effect of age on geriatric depression scale performance in Parkinson's disease Movement Disorders. 22: 1331-1335. PMID 17546674 DOI: 10.1002/mds.21369 |
0.387 |
|
| 2007 |
Dahodwala N, Connolly J, Farmer J, Stern MB, Jennings D, Siderowf A. Interest in predictive testing for Parkinson's disease: impact of neuroprotective therapy. Parkinsonism & Related Disorders. 13: 495-9. PMID 17449316 DOI: 10.1016/j.parkreldis.2007.02.010 |
0.399 |
|
| 2007 |
Goetz CG, Fahn S, Martinez-Martin P, Poewe W, Sampaio C, Stebbins GT, Stern MB, Tilley BC, Dodel R, Dubois B, Holloway R, Jankovic J, Kulisevsky J, Lang AE, Lees A, et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan. Movement Disorders : Official Journal of the Movement Disorder Society. 22: 41-7. PMID 17115387 DOI: 10.1002/mds.21198 |
0.367 |
|
| 2006 |
Liang GS, Chou KL, Baltuch GH, Jaggi JL, Loveland-Jones C, Leng L, Maccarone H, Hurtig HI, Colcher A, Stern MB, Kleiner-Fisman G, Simuni T, Siderowf AD. Long-term outcomes of bilateral subthalamic nucleus stimulation in patients with advanced Parkinson's disease Stereotactic and Functional Neurosurgery. 84: 221-227. PMID 17063043 DOI: 10.1159/000096495 |
0.372 |
|
| 2006 |
Weaver FM, Stern MB, Follett K. Deep-brain stimulation in Parkinson's disease Lancet Neurology. 5: 900-901. PMID 17052655 DOI: 10.1016/S1474-4422(06)70586-5 |
0.343 |
|
| 2006 |
Weintraub D, Taraborelli D, Morales KH, Duda JE, Katz IR, Stern MB. Escitalopram for major depression in Parkinson's disease: an open-label, flexible-dosage study. The Journal of Neuropsychiatry and Clinical Neurosciences. 18: 377-83. PMID 16963587 DOI: 10.1176/appi.neuropsych.18.3.377 |
0.332 |
|
| 2006 |
deMarcaida JA, Schwid SR, White WB, Blindauer K, Fahn S, Kieburtz K, Stern M, Shoulson I. Effects of tyramine administration in Parkinson's disease patients treated with selective MAO-B inhibitor rasagiline. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 1716-21. PMID 16856145 DOI: 10.1002/Mds.21048 |
0.396 |
|
| 2006 |
Weintraub D, Siderowf AD, Potenza MN, Goveas J, Morales KH, Duda JE, Moberg PJ, Stern MB. Association of dopamine agonist use with impulse control disorders in Parkinson disease. Archives of Neurology. 63: 969-73. PMID 16831966 DOI: 10.1001/Archneur.63.7.969 |
0.399 |
|
| 2006 |
Siderowf A, Stern MB. Preclinical diagnosis of Parkinson's disease: Are we there yet? Current Neurology and Neuroscience Reports. 6: 295-301. PMID 16822349 DOI: 10.1007/s11910-006-0021-z |
0.428 |
|
| 2006 |
Weintraub D, Morales KH, Duda JE, Moberg PJ, Stern MB. Frequency and correlates of co-morbid psychosis and depression in Parkinson's disease. Parkinsonism & Related Disorders. 12: 427-31. PMID 16797214 DOI: 10.1016/j.parkreldis.2006.03.006 |
0.342 |
|
| 2006 |
Siderowf A, Stern M. Clinical trials with rasagiline: evidence for short-term and long-term effects. Neurology. 66: S80-8. PMID 16717255 DOI: 10.1212/WNL.66.10_SUPPL_4.S80 |
0.39 |
|
| 2006 |
Blindauer K, Shoulson I, Oakes D, Kieburtz K, Schwid S, Fahn S, Stern M, Goetz C, Nutt J, Goren S, Sayag N, Scolnik M, Levy R, Eyal E, Salzman P, et al. A randomized controlled trial of etilevodopa in patients with Parkinson disease who have motor fluctuations. Archives of Neurology. 63: 210-6. PMID 16476809 DOI: 10.1001/Archneur.63.2.210 |
0.397 |
|
| 2006 |
Weintraub D, Oehlberg KA, Katz IR, Stern MB. Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 169-75. PMID 16473982 DOI: 10.1097/01.JGP.0000192488.66049.4b |
0.313 |
|
| 2006 |
Weintraub D, Cary MS, Stern MB, Taraborelli D, Katz IR. Daily affect in Parkinson disease is responsive to life events and motor symptoms. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 14: 161-8. PMID 16473981 DOI: 10.1097/01.JGP.0000192494.96543.f4 |
0.418 |
|
| 2006 |
Siderowf A, Jaggi JL, Xie SX, Loveland-Jones C, Leng L, Hurtig H, Colcher A, Stern M, Chou KL, Liang G, Maccarone H, Simuni T, Baltuch G. Long-term effects of bilateral subthalamic nucleus stimulation on health-related quality of life in advanced Parkinson's disease. Movement Disorders. 21: 746-753. PMID 16463342 DOI: 10.1002/Mds.20786 |
0.365 |
|
| 2006 |
Biglan KM, Schwid S, Eberly S, Blindauer K, Fahn S, Goren T, Kieburtz K, Oakes D, Plumb S, Siderowf A, Stern M, Shoulson I. Rasagiline improves quality of life in patients with early Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 21: 616-23. PMID 16450340 DOI: 10.1002/Mds.20764 |
0.364 |
|
| 2005 |
Weaver F, Follett K, Hur K, Ippolito D, Stern M. Deep brain stimulation in Parkinson disease: a metaanalysis of patient outcomes. Journal of Neurosurgery. 103: 956-67. PMID 16381181 DOI: 10.3171/jns.2005.103.6.0956 |
0.362 |
|
| 2005 |
Robinson K, Dennison A, Roalf D, Noorigian J, Cianci H, Bunting-Perry L, Moberg P, Kleiner-Fisman G, Martine R, Duda J, Jaggi J, Stern M. Falling risk factors in Parkinson's disease Neurorehabilitation. 20: 169-182. PMID 16340098 DOI: 10.3233/Nre-2005-20304 |
0.353 |
|
| 2005 |
Weintraub D, Stern MB. Psychiatric complications in Parkinson disease American Journal of Geriatric Psychiatry. 13: 844-851. PMID 16223962 DOI: 10.1097/00019442-200510000-00003 |
0.422 |
|
| 2005 |
Weintraub D, Moberg PJ, Culbertson WC, Duda JE, Katz IR, Stern MB. Dimensions of executive function in Parkinson's disease. Dementia and Geriatric Cognitive Disorders. 20: 140-4. PMID 16020942 DOI: 10.1159/000087043 |
0.401 |
|
| 2005 |
Weintraub D, Morales KH, Moberg PJ, Bilker WB, Balderston C, Duda JE, Katz IR, Stern MB. Antidepressant studies in Parkinson's disease: a review and meta-analysis. Movement Disorders : Official Journal of the Movement Disorder Society. 20: 1161-9. PMID 15954137 DOI: 10.1002/Mds.20555 |
0.409 |
|
| 2005 |
Siderowf A, Newberg A, Chou KL, Lloyd M, Colcher A, Hurtig HI, Stern MB, Doty RL, Mozley PD, Wintering N, Duda JE, Weintraub D, Moberg PJ. [99mTc]TRODAT-1 SPECT imaging correlates with odor identification in early Parkinson disease. Neurology. 64: 1716-20. PMID 15911797 DOI: 10.1212/01.WNL.0000161874.52302.5D |
0.399 |
|
| 2004 |
Stern MB. Dopamine agonists modify the course of Parkinson disease Archives of Neurology. 61: 1969-1971. PMID 15596624 DOI: 10.1001/archneur.61.12.1969 |
0.333 |
|
| 2004 |
Horn S, Stern MB. The comparative effects of medical therapies for Parkinson's disease Neurology. 63: S7-S12. PMID 15477585 |
0.34 |
|
| 2004 |
Olanow CW, Kieburtz K, Stern M, Watts R, Langston JW, Guarnieri M, Hubble J. Double-blind, placebo-controlled study of entacapone in levodopa-treated patients with stable Parkinson disease. Archives of Neurology. 61: 1563-8. PMID 15477510 DOI: 10.1001/ARCHNEUR.61.10.1563 |
0.433 |
|
| 2004 |
Jaggi JL, Umemura A, Hurtig HI, Siderowf AD, Colcher A, Stern MB, Baltuch GH. Bilateral stimulation of the subthalamic nucleus in Parkinson's disease: Surgical efficacy and prediction of outcome Stereotactic and Functional Neurosurgery. 82: 104-114. PMID 15305083 DOI: 10.1159/000078145 |
0.349 |
|
| 2004 |
Stern MB, Marek KL, Friedman J, Hauser RA, LeWitt PA, Tarsy D, Olanow CW. Double-blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients Movement Disorders. 19: 916-923. PMID 15300656 DOI: 10.1002/mds.20145 |
0.394 |
|
| 2004 |
Stern MB. The preclinical detection of Parkinson's disease: Ready for prime time? Annals of Neurology. 56: 169-171. PMID 15293267 DOI: 10.1002/ana.20180 |
0.36 |
|
| 2004 |
Chou KL, Hurtig HI, Stern MB, Colcher A, Ravina B, Newberg A, Mozley PD, Siderowf A. Diagnostic accuracy of [99mTc]TRODAT-1 SPECT imaging in early Parkinson's disease Parkinsonism and Related Disorders. 10: 375-379. PMID 15261880 DOI: 10.1016/j.parkreldis.2004.04.002 |
0.415 |
|
| 2004 |
Li YJ, Hauser MA, Scott WK, Martin ER, Booze MW, Qin XJ, Walter JW, Nance MA, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Goetz CG, et al. Apolipoprotein E controls the risk and age at onset of Parkinson disease. Neurology. 62: 2005-9. PMID 15184605 DOI: 10.1212/01.Wnl.0000128089.53030.Ac |
0.406 |
|
| 2004 |
Weintraub D, Moberg PJ, Duda JE, Katz IR, Stern MB. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease. Journal of the American Geriatrics Society. 52: 784-8. PMID 15086662 DOI: 10.1111/J.1532-5415.2004.52219.X |
0.408 |
|
| 2004 |
Culbertson WC, Moberg PJ, Duda JE, Stern MB, Weintraub D. Assessing the executive function deficits of patients with Parkinson's disease: utility of the Tower of London-Drexel. Assessment. 11: 27-39. PMID 14994951 DOI: 10.1177/1073191103258590 |
0.421 |
|
| 2003 |
Oliveira SA, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons KE, Pahwa R, Stern MB, Hiner BC, Jankovic J, Ondo WG, Allen FH, Scott BL, Goetz CG, et al. Association study of Parkin gene polymorphisms with idiopathic Parkinson disease. Archives of Neurology. 60: 975-80. PMID 12873854 DOI: 10.1001/Archneur.60.7.975 |
0.406 |
|
| 2003 |
Lee C, Grossman M, Morris J, Stern MB, Hurtig HI. Attentional resource and processing speed limitations during sentence processing in Parkinson's disease Brain and Language. 85: 347-356. PMID 12744946 DOI: 10.1016/S0093-934X(03)00063-4 |
0.38 |
|
| 2003 |
Oliveira SA, Scott WK, Martin ER, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Ondo WG, Allen FH, Scott BL, Goetz CG, Small GW, et al. Parkin mutations and susceptibility alleles in late-onset Parkinson's disease. Annals of Neurology. 53: 624-9. PMID 12730996 DOI: 10.1002/Ana.10524 |
0.369 |
|
| 2003 |
Siderowf A, Stern M. Update on Parkinson disease. Annals of Internal Medicine. 138: 651-8. PMID 12693888 DOI: 10.7326/0003-4819-138-8-200304150-00013 |
0.388 |
|
| 2003 |
van der Walt JM, Martin ER, Scott WK, Zhang F, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, et al. Genetic polymorphisms of the N-acetyltransferase genes and risk of Parkinson's disease. Neurology. 60: 1189-91. PMID 12682333 DOI: 10.1212/01.Wnl.0000055929.84668.9A |
0.361 |
|
| 2003 |
Grossman M, Cooke A, DeVita C, Lee C, Alsop D, Detre J, Gee J, Chen W, Stern MB, Hurtig HI. Grammatical and resource components of sentence processing in Parkinson's disease: an fMRI study. Neurology. 60: 775-81. PMID 12629232 DOI: 10.1212/01.WNL.0000044398.73241.13 |
0.324 |
|
| 2003 |
van der Walt JM, Nicodemus KK, Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Haines JL, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, et al. Mitochondrial polymorphisms significantly reduce the risk of Parkinson disease. American Journal of Human Genetics. 72: 804-11. PMID 12618962 DOI: 10.1086/373937 |
0.37 |
|
| 2002 |
Shults CW, Oakes D, Kieburtz K, Beal MF, Haas R, Plumb S, Juncos JL, Nutt J, Shoulson I, Carter J, Kompoliti K, Perlmutter JS, Reich S, Stern M, Watts RL, et al. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Archives of Neurology. 59: 1541-50. PMID 12374491 DOI: 10.1001/Archneur.59.10.1541 |
0.358 |
|
| 2002 |
Simuni T, Jaggi JL, Mulholland H, Hurtig HI, Colcher A, Siderowf AD, Ravina B, Skolnick BE, Goldstein R, Stern MB, Baltuch GH. Bilateral stimulation of the subthalamic nucleus in patients with Parkinson disease: A study of efficacy and safety Journal of Neurosurgery. 96: 666-672. PMID 11990805 |
0.407 |
|
| 2002 |
Grossman M, Zurif E, Lee C, Prather P, Kalmanson J, Stern MB, Hurtig HI. Information processing speed and sentence comprehension in Parkinson's disease. Neuropsychology. 16: 174-81. PMID 11949709 DOI: 10.1037//0894-4105.16.2.174 |
0.421 |
|
| 2002 |
Cantor CR, Stern MB. Dopamine agonists and sleep in Parkinson's disease. Neurology. 58: S71-8. PMID 11909988 |
0.32 |
|
| 2002 |
Grossman M, Lee C, Morris J, Stern MB, Hurtig HI. Assessing resource demands during sentence processing in Parkinson's disease Brain and Language. 80: 603-616. PMID 11896660 DOI: 10.1006/brln.2001.2630 |
0.421 |
|
| 2002 |
Li YJ, Scott WK, Hedges DJ, Zhang F, Gaskell PC, Nance MA, Watts RL, Hubble JP, Koller WC, Pahwa R, Stern MB, Hiner BC, Jankovic J, Allen FA, Goetz CG, et al. Age at onset in two common neurodegenerative diseases is genetically controlled. American Journal of Human Genetics. 70: 985-93. PMID 11875758 DOI: 10.1086/339815 |
0.386 |
|
| 2001 |
Martin ER, Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, et al. Association of single-nucleotide polymorphisms of the tau gene with late-onset Parkinson disease. Jama. 286: 2245-50. PMID 11710889 DOI: 10.1001/Jama.286.18.2245 |
0.339 |
|
| 2001 |
Scott WK, Nance MA, Watts RL, Hubble JP, Koller WC, Lyons K, Pahwa R, Stern MB, Colcher A, Hiner BC, Jankovic J, Ondo WG, Allen FH, Goetz CG, Small GW, et al. Complete genomic screen in Parkinson disease: evidence for multiple genes. Jama. 286: 2239-44. PMID 11710888 DOI: 10.1001/Jama.286.18.2239 |
0.398 |
|
| 2001 |
Grossman M, Glosser G, Kalmanson J, Morris J, Stern MB, Hurtig HI. Dopamine supports sentence comprehension in Parkinson's Disease. Journal of the Neurological Sciences. 184: 123-30. PMID 11239945 DOI: 10.1016/S0022-510X(00)00491-3 |
0.39 |
|
| 2000 |
Grossman M, Kalmanson J, Bernhardt N, Morris J, Stern MB, Hurtig HI. Cognitive resource limitations during sentence comprehension in Parkinson's disease. Brain and Language. 73: 1-16. PMID 10872635 DOI: 10.1006/brln.2000.2290 |
0.394 |
|
| 2000 |
Siderowf AD, Holloway RG, Stern MB. Cost-effectiveness analysis in Parkinson's disease: Determining the value of interventions Movement Disorders. 15: 439-445. PMID 10830407 DOI: 10.1002/1531-8257(200005)15:3<439::AID-MDS1004>3.0.CO;2-F |
0.305 |
|
| 1999 |
Simuni T, Stern MB. Does levodopa accelerate Parkinson's disease? Drugs and Aging. 14: 399-408. PMID 10408739 DOI: 10.2165/00002512-199914060-00001 |
0.431 |
|
| 1998 |
Simuni T, Stern MB. Diagnosis and epidemiology of Parkinson's disease Cns Spectrums. 3: 23-35. |
0.344 |
|
| 1997 |
Stern MB. Contemporary approaches to the pharmacotherapeutic management of Parkinson's disease: An overview Neurology. 49: S2-S9. PMID 9222270 DOI: 10.1212/WNL.49.1_Suppl_1.S2 |
0.411 |
|
| 1997 |
Stern MB. The changing standard of care in Parkinson's disease: Current concepts and controversies Neurology. 49: S1. PMID 9222269 DOI: 10.1212/WNL.49.1_SUPPL_1.S1 |
0.325 |
|
| 1997 |
Adler CH, Stern MB, Vernon G, Hurtig HI. Amantadine in advanced Parkinson's disease: Good use of an old drug [2] Journal of Neurology. 244: 336-337. PMID 9178162 DOI: 10.1007/s004150050098 |
0.334 |
|
| 1997 |
Stern MB, Freese A. Parkinson's disease: The case for novel treatment strategies Experimental Neurology. 144: 2-3. PMID 9126142 DOI: 10.1006/exnr.1996.6378 |
0.376 |
|
| 1996 |
Freese A, Stern M, Kaplitt MG, O'Connor WM, Abbey MV, O'Connor MJ, During MJ. Prospects for gene therapy in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 11: 469-88. PMID 8866488 DOI: 10.1002/Mds.870110502 |
0.331 |
|
| 1996 |
Hutton JT, Koller WC, Ahlskog JE, Pahwa R, Hurtig HI, Stern MB, Hiner BC, Lieberman A, Pfeiffer RF, Rodnitzky RL, Waters CH, Muenter MD, Adler CH, Morris JL. Multicenter, placebo-controlled trial of cabergoline taken once daily in the treatment of Parkinson's disease Neurology. 46: 1062-1065. PMID 8780092 |
0.397 |
|
| 1995 |
Glosser G, Clark C, Freundlich B, Kliner-Krenzel L, Flaherty P, Stern M. A controlled investigation of current and premorbid personality: characteristics of Parkinson's disease patients. Movement Disorders : Official Journal of the Movement Disorder Society. 10: 201-6. PMID 7753062 DOI: 10.1002/Mds.870100211 |
0.435 |
|
| 1995 |
Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson's disease: development of optimal discrimination criteria. Neurodegeneration : a Journal For Neurodegenerative Disorders, Neuroprotection, and Neuroregeneration. 4: 93-7. PMID 7600189 DOI: 10.1006/neur.1995.0011 |
0.416 |
|
| 1994 |
Stern MB, Doty RL, Dotti M, Corcoran P, Crawford D, McKeown DA, Adler C, Gollomp S, Hurtig H. Olfactory function in Parkinson's disease subtypes. Neurology. 44: 266-8. PMID 8309571 DOI: 10.1212/Wnl.44.2.266 |
0.444 |
|
| 1994 |
Olanow CW, Fahn S, Muenter M, Klawans H, Hurtig H, Stern M, Shoulson I, Kurlan R, Grimes JD, Jankovic J. A multicenter double-blind placebo-controlled trial of pergolide as an adjunct to Sinemet in Parkinson's disease. Movement Disorders : Official Journal of the Movement Disorder Society. 9: 40-7. PMID 8139604 DOI: 10.1002/Mds.870090107 |
0.357 |
|
| 1993 |
Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease. Neurology. 43: 962-5. PMID 8492953 DOI: 10.1212/Wnl.43.5.962 |
0.425 |
|
| 1992 |
Grossman M, Carvell S, Stern MB, Gollomp S, Hurtig HI. Sentence comprehension in Parkinson's disease: The role of attention and memory Brain and Language. 42: 347-384. PMID 1611464 DOI: 10.1016/0093-934X(92)90074-O |
0.392 |
|
| 1992 |
Doty RL, Stern MB, Pfeiffer C, Gollomp SM, Hurtig HI. Bilateral olfactory dysfunction in early stage treated and untreated idiopathic Parkinson's disease. Journal of Neurology, Neurosurgery, and Psychiatry. 55: 138-42. PMID 1538221 DOI: 10.1136/Jnnp.55.2.138 |
0.429 |
|
| 1992 |
Grossman M, Crino P, Reivich M, Stern MB, Hurtig HI. Attention and sentence processing deficits in Parkinson's disease: the role of anterior cingulate cortex. Cerebral Cortex (New York, N.Y. : 1991). 2: 513-25. PMID 1477527 DOI: 10.1093/Cercor/2.6.513 |
0.348 |
|
| 1991 |
Stern MB. Head trauma as a risk factor for Parkinson's disease Movement Disorders. 6: 95-97. PMID 2057017 |
0.336 |
|
| 1991 |
Stern M, Dulaney E, Gruber SB, Golbe L, Bergen M, Hurtig H, Gollomp S, Stolley P. The Epidemiology of Parkinson's Disease: A Case-Control Study of Young-Onset and Old-Onset Patients Archives of Neurology. 48: 903-907. PMID 1953412 DOI: 10.1001/archneur.1991.00530210029018 |
0.428 |
|
| 1991 |
Grossman M, Carvell S, Gollomp S, Stern MB, Vernon G, Hurtig HI. Sentence comprehension and praxis deficits in parkinson’s disease Neurology. 41: 1620-1626. PMID 1922805 DOI: 10.1212/Wnl.41.10.1620 |
0.418 |
|
| 1991 |
Stern MB. Electroconvulsive therapy in untreated Parkinson's disease [1] Movement Disorders. 6: 265. PMID 1922134 |
0.358 |
|
| 1989 |
Stern MB, Braffman BH, Skolnick BE, Hurtig HI, Grossman RI. Magnetic resonance imaging in Parkinson’s disease and parkinsonian syndromes Neurology. 39: 1524-1526. PMID 2812334 |
0.427 |
|
| 1989 |
Braffman BH, Grossman RI, Goldberg HI, Stern MB, Hurtig HI, Hackney DB, Bilaniuk LT, Zimmerman RA. MR imaging of Parkinson disease with spin-echo and gradient-echo sequences American Journal of Roentgenology. 152: 159-165. PMID 2783271 |
0.31 |
|
| 1986 |
Stern MB, Gur RC, Saykin AJ, Hurtig HI. Dementia of Parkinson's disease and Alzheimer's disease. Is there is a difference? Journal of the American Geriatrics Society. 34: 475-478. PMID 3700936 DOI: 10.1111/J.1532-5415.1986.Tb03416.X |
0.35 |
|
| 1985 |
Hurtig HI, Stern MB. Thalamotomy for Parkinson's disease Journal of Neurosurgery. 62: 163-165. PMID 3964852 |
0.391 |
|
| Show low-probability matches. |
